SKIP TO SITE NAVIGATION | SWITCH TO GRAPHICAL VERSION
ROBERT A. INGRAM, board member since 2001
Robert A. Ingram is vice chairman-Pharmaceuticals of GlaxoSmithKline, a pharmaceutical research and development company in Research Triangle Park, N.C. He is chairman of the board, OSI Pharmaceuticals Inc., Melville, New York, a biotechnology company, and lead director, Valeant Pharmaceuticals International, Aliso Viejo, California, a specialty pharmaceutical company focused on neurology, dermatology and infectious disease. He previously served as chief operating officer and president, Pharmaceutical Operations, of GlaxoSmithKline plc., and chairman of Valeant Pharmaceuticals International.
Wachovia Board Committees: Corporate Governance & Nominating (Chair), Executive, Management Resources & Compensation
Other Directorships: Allergan, Inc.; Edwards Lifesciences Corporation; Lowe’s Companies, Inc.; OSI Pharmaceuticals, Inc., and Valeant Pharmaceuticals International
Date of Birth: December 6, 1942
About Wachovia